« Return to News | Clinical Intelligence

The CenterWatch Monthly, December 2011

Thursday, December 1, 2011 09:46 AM

Canada scrambles to reboot sagging clinical trials market

Canada has seen a precipitous drop in research and has the newly earned distinction of being the world’s biggest loser of investigative sites and enrolled patients in a benchmark comparison study, a downward trend particularly startling for a country that only six years ago was considered the world leader in recruitment reliability. A confluence of factors has made Canada a slow and expensive location for trials, and rebooting the market will require...

Supply chain partnerships morphing into strategic alliances

As happened with CROs a few years ago, supply chain relationships are moving from a tactical, single-trial model toward strategic alliances with a smaller number of key vendors. And both big pharma and biotech are embracing the idea in the name of efficiency and...

Eye On Eli Lilly

Eli Lilly has a history of innovation beginning in 1876 and is now the tenth largest pharmaceutical company worldwide. Its global presence includes clinical research performed in more than 50 countries. Lilly’s R&D focus is to generate potential biotech solutions for a wide range of diseases, and to pursue personalized medicines...

 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.